Histotripsy, a non-invasive method used to destroy liver tumors using focused sound waves, shows low rates of immediate procedural complications, but real-world data indicates that the safety of the treatment itself does not guarantee clinical benefit for all patient categories.
Researchers from UVA Health analyzed outcomes of the method between 2023 and 2026, finding that 11% of 972 patients died within 30 days following the procedure.
The tech…
Read with caution - this story is only being covered by one news source that has a ‘low factuality’ rating, which means the outlet has a history of poor reporting practices. Learn more about factuality ratings here.